VF
AGRX

Virtu Financial’s Agile Therapeutics AGRX Stock Holding History

Virtu Financial’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,378
Closed -$27K – 2417
2023
Q1 		$27K Sell
2,378
-476
-17% -$6.11K ﹤0.01% 1193
2022
Q4 		$32K Buy
+2,854
New +$33.2K ﹤0.01% 1169
2022
Q1 		– Sell
-119
Closed -$116K – 2328
2021
Q4 		$116K Buy
119
+105
+750% +$148K 0.01% 1069
2021
Q3 		$26K Buy
14
+7
+100% +$15.8K ﹤0.01% 1365
2021
Q2 		$17K Buy
+7
New +$23.1K ﹤0.01% 1414
2021
Q1 		– Sell
-8
Closed -$48K – 2213
2020
Q4 		$48K Sell
8
-30
-79% -$177K 0.01% 1239
2020
Q3 		$231K Buy
+38
New +$218K 0.04% 540
2019
Q4 		$45K Buy
+9
New +$31.4K ﹤0.01% 1220
2019
Q2 		– Sell
-29
Closed -$88K – 1989
2019
Q1 		$88K Buy
29
+2
+7% +$4.24K 0.01% 1147
2018
Q4 		$31K Sell
27
-16
-37% -$24.5K ﹤0.01% 1335
2018
Q3 		$32K Buy
43
+32
+291% +$23.4K ﹤0.01% 1363
2018
Q2 		$11K Sell
11
-4
-27% -$14K ﹤0.01% 1899
2018
Q1 		$76K Sell
15
-28
-65% -$185K ﹤0.01% 1634
2017
Q4 		$232K Buy
43
+1
+2% +$9.31K 0.01% 1517
2017
Q3 		$374K Buy
+42
New +$323K 0.02% 1174

Other funds holding AGRX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Virtu Financial's AGRX Position: Q2 2023 in Review

Virtu Financial sold out of Agile Therapeutics (AGRX) in Q2 2023, closing a stake of 2,378 shares — an estimated $27K sold.

Virtu Financial first reported a position in AGRX in Q3 2017 and held it in 15 quarters. The position peaked at $374K in Q3 2017. 16 funds tracked by Wall St. Rank hold AGRX as of Q2 2023.

  • Virtu Financial reported no remaining Agile Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 2,378 Agile Therapeutics shares in Q2 2023, an estimated $27K.
  • Virtu Financial first reported a position in Agile Therapeutics in Q3 2017 and held it in 15 quarters.
  • Virtu Financial's Agile Therapeutics position peaked at $374K in Q3 2017.
  • 16 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.